Stock Spotlights Archives - Page 286 of 422

FridayFeb 01, 2019 3:20 pm

NetworkNewsBreaks – Icon Exploration Inc. (TSX.V: IEX.H) Aims to Capitalize on the Medical and Recreational Cannabis Markets

Icon Exploration (TSX.V: IEX.H), a company working toward establishing its foothold in the global cannabis sector, is planning on operating within both the medical and recreational cannabis markets. An article discussing the company reads, “In what is a win-win situation for Icon, the company has placed bets on both recreational and medical cannabis. This legal market is growing at double-digit rates, and capitalizing on that growth, Icon is aiming to create a well-diversified company that produces long-term returns for shareholders. To do so, it intends to be a leading purveyor of medicinal and recreational cannabis while, at the same time,…

FridayFeb 01, 2019 3:16 pm

NetworkNewsBreaks – BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Advances Development of Personalized Immunotherapy Solution for Cancer Patients

BriaCell Therapeutics (OTCQB: BCTXF) (TSX.V: BCT), a biotechnology company focused on immuno-oncology, is advancing the development of a cost-saving solution for cancer patients. An article discussing the company reads, “BriaCell’s development of Bria-OTS, a personalized immunotherapy solution that matches the needs of the patient without a specialized manufacturing process, is designed to mitigate some of those worries. This personalized treatment is expected to be safe and highly effective while avoiding the high costs of creating personalized treatments for advanced cancer patients. In addition, Bria-OTS is created to produce a selective immune response that’s tailored to the specific needs of the…

ThursdayJan 31, 2019 3:07 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Seeks to Improve Lives through Revolutionary Nicotine Delivery Method

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) recently announced that its wholly owned subsidiary, Lexaria Nicotine LLC, has joined forces with one of the world’s largest tobacco companies to fund the research and development of Lexaria’s patented DehydraTECH technology to potentially commercialize a form of oral nicotine delivery. An article discussing the company reads, “Lexaria’s goal is to create an oral product that eliminates the need for inhalation and helps curb the smoking habits of consumers. Over 6 million deaths a year worldwide are attributed to nicotine delivery through smoking. The company believes that its DehydraTECH technology may help the 69…

ThursdayJan 31, 2019 2:38 pm

NetworkNewsBreaks – Golden Developing Solutions Inc.’s (DVLP) Recent WheresCBD.com Launch Expands Hemp-related Products Strategy

Golden Developing Solutions (OTC: DVLP), an emerging leader in the cannabis, hemp, and cannabidiol (CBD) marketplace, recently furthered its hemp-related product strategy with the launch of WheresCBD.com. An article discussing the company reads, “DVLP recently expanded its hemp-related products strategy with the launch of WheresCBD.com. For consumers looking for high-end hemp oil and cannabidiol isolates, the new site will gather together information on nationwide cannabidiol products (http://nnw.fm/pgVr5). WheresCBD.com will be populated by the most popular cannabidiol products. These products include gummy bears and leading cannabidiol oils. With the signing of the 2018 Farm Bill legalizing hemp, the door is open…

WednesdayJan 30, 2019 1:44 pm

NetworkNewsBreaks – Spectrum Global Solutions Inc. (SGSI) Employs Strategy to Build Market Share, Leverage Organic Revenue and Margin Growth

Through its various subsidiaries, Spectrum Global Solutions (OTCQB: SGSI) provides services directly to carriers, aggregators, utilities, enterprise clients, project management organizations and original equipment manufacturers. The company is currently employing a carefully designed growth strategy that includes, in part, acquisitions. A recent article discussing the company reads, “The company’s growth strategy also aims to build market share and leverage organic revenue and margin growth. This involves focusing its sales team at new service provider targets, growing corporate margins and establishing new PMO and OEM partnerships. This strategy also aims to expand SGSI’s service footprint and open the door for new…

WednesdayJan 30, 2019 1:40 pm

NetworkNewsBreaks – QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Advances Irgon Lithium Mine Project Toward Mining Production

QMC Quantum Minerals (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) is currently anticipating the completion of an updated NI 43–101 resource report on its Irgon Lithium Mine Project, in which the company holds a 100 percent undivided interest. An article discussing the company reads, “QMC’s efforts to supply a domestic source of lithium have focused on previously explored but underdeveloped hard rock mineral sites in southern Canada. Historically, North America’s hard rock miners dominated the lithium industry until the 1980s by extracting the white metal from the mineral spodumene, which, as a lithium aluminum inosilicate, is a source of lithium and…

MondayJan 28, 2019 3:03 pm

NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Positions Itself to Become a Universal Player in the CBD-based Product Industry

ChineseInvestors.com (OTCQB: CIIX), developer of a proprietary financial news media and content platform targeting the global Chinese-speaking community, is aiming to capitalize on the increased demand for cannabidiol-based health and wellness products in the United States and abroad. A recent article further discussing the company reads, “ChineseInvestors.com, Inc. (OTCQB: CIIX), a premier provider of financial information to Chinese-speaking investors in the United States and China, recently announced the appointment of Alex Hamilton as chief financial officer of CBD Biotechnology, LTD, the company’s wholly owned subsidiary. Hamilton will be supervising a myriad of corporate responsibilities within the company and, ultimately, aims…

MondayJan 28, 2019 2:32 pm

NetworkNewsBreaks – Plus Products Inc. (CSE: PLUS) Recognized as a Leader in a Budding Sector of the Marijuana Industry

Plus Products (CSE: PLUS) has made a name for itself in California as the state’s leading cannabis-infused edibles brand. An article discussing the company reads, “Cannabis-infused food and drink has been a growing sector of the marijuana industry, particularly in California, as legalization legislation has moved slowly through both the country and the world. In 2017, consumers in the Golden State purchased $180 million worth of cannabis-infused food and drink (10 percent of the state’s total marijuana sales). That percentage grew to 18 percent in February 2018, and with the increasing quality and innovation seen with baked good edibles, that…

MondayJan 28, 2019 2:01 pm

NetworkNewsBreaks – Kontrol Energy Corp.’s (CSE: KNR) (OTC: OTSHF) (FSE: 1K8) Smart-Energy Solutions Could Cut Cannabis Cultivation Costs

Ontario-based tech company Kontrol Energy (CSE: KNR) (OTC: OTSHF) (FSE: 1K8) engages in the integration of smart-energy technologies and solutions to deliver energy cost savings and reduced greenhouse gas emissions to both commercial and industrial properties. The company is utilizing this strategy to help companies cut costs in the booming cannabis industry. An article discussing the company reads, “Energy costs are a big part of the equation. Using traditional growing methods, it takes about 2,000 kilowatt-hours (kWh) of electricity to produce a pound of cannabis product. That’s roughly the same energy consumption as an average household over a period of…

FridayJan 25, 2019 3:52 pm

NetworkNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Patented Drug Delivery Platform Could Revolutionize Nicotine Delivery

Biotechnology company and drug delivery platform innovator Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) technology is patent protected for cannabidiol and all other nonpsychoactive cannabinoids. The company also currently has patents pending for THC, nonsteroidal anti-inflammatory drugs (NSAIDs), nicotine, other psychoactive cannabinoids and other molecules. An article discussing the company reads, “Lexaria Bioscience has 10 patents granted with over 50 patents pending. Four of the granted patents focus on the delivery of nicotine. The company is not partnering with the tobacco industry. However, Bunka informed that Lexaria is exploring the potential use of its DehydraTECH technology to help people stop smoking.…

Financial news and publishing for public and private companies

Contact us: 212.418.1217

Breaks Categories: Stock Spotlights